Save time and get answers to complex questions with AI chat
Tracleer online pharmacy?Albendazole side effects in humans?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Drugpatentwatch skyrizi biologic patent analysis?Mebendazole ingredients?
See the DrugPatentWatch profile for xifaxan
Xifaxan (rifaximin) has been on the market since 2004, when the FDA approved it. That means it has been available for about 22 years as of 2026. [1]
Most people mean the original FDA approval date when they ask how long a drug has been on the market. Xifaxan’s first approval was in 2004, even though additional indications and formulations may have been added later. [1]
DrugPatentWatch.com tracks drug patent and regulatory history and can help confirm the initial FDA approval timing for Xifaxan. [1]
[1] DrugPatentWatch.com – Xifaxan (rifaximin) drug information
Other Questions About Xifaxan :